Accurately Identify Referable DR Patients in Minutes

NO HUMAN GRADING NECESSARY

Lorem ipsum dolor sit amet

Maecenas ut ornare felis. Ut semper mattis leo quis consequat. Vestibulum commodo eleifend tempor. Aliquam erat volutpat. Phasellus at quam eget risus pulvinar semper.

Diabetic Retinopathy

Currently diabetic retinopathy (DR) causes 12,000 to 24,000 new cases of blindness each year in the U.S, and is the leading cause of blindness among adults aged 20–74 years.

How can EyeMark help?

Tracking progression manually today by human graders is time consuming and error-prone, involving careful alignment of images across multiple patient visits, followed by marking and comparison of individual microaneurysms by hand.

How does EyeMark work?

A visiting patient is imaged by an eye care professional using a commercial fundus camera and the fundus images are input to EyeMark. The software automatically analyzes and grades the images (for current visit and all available previous visits), and issues a simple, quantitative report.

Technology behind EyeMark

Presently MA turnover measurement involves two steps: careful alignment of current and baseline images, and marking of individual MAs. This process is very time consuming and prone to error, if done by entirely by human graders.

Lorem ipsum dolor

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.

Rectangle 5

Lorem ipsum dolor

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque urna elit, varius sed orci in, tempor pretium metus. Vestibulum vel nibh in arcu sodales pulvinar.

Curabitur et quam a lacus tempor consectetur sed ut augue.

Lorem ipsum dolor

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque urna elit, varius sed orci in, tempor pretium metus. Vestibulum vel nibh in arcu sodales pulvinar.

Curabitur et quam a lacus tempor consectetur sed ut augue.

Rectangle 5
Rectangle 5

Lorem ipsum dolor

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque urna elit, varius sed orci in, tempor pretium metus. Vestibulum vel nibh in arcu sodales pulvinar.

Curabitur et quam a lacus tempor consectetur sed ut augue.

I believe that an automated, reliable DR screening tool such as EyeArt™ would empower primary care providers to better manage their patients with diabetes.

John Doe,

Designation

I believe that an automated, reliable DR screening tool such as EyeArt™ would empower primary care providers to better manage their patients with diabetes.

— Srinivas Sadda, MD,

President and CSO, Doheny Eye Institute

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Jane Doe

Interested In

Free 30 Minute Evaluation

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque urna elit, varius sed orci in, tempor pretium metus. Vestibulum vel nibh in arcu sodales pulvinar. Curabitur et quam a lacus tempor

Call to Action Form - Home Page

We are more than happy to answer any question you may have about any of our products. Fill out the form below and someone from our team will get back to you promptly.